GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,156,000 | -83.2% | 50,000 | -83.3% | 0.36% | -72.1% |
| Q4 2014 | $12,822,000 | -13.8% | 300,000 | -7.3% | 1.28% | +0.3% |
| Q3 2014 | $14,871,000 | -14.0% | 323,500 | 0.0% | 1.27% | -4.4% |
| Q2 2014 | $17,301,000 | +0.1% | 323,500 | 0.0% | 1.33% | +2.6% |
| Q1 2014 | $17,285,000 | -23.6% | 323,500 | -23.6% | 1.30% | -19.6% |
| Q4 2013 | $22,611,000 | +1817.8% | 423,500 | +1702.1% | 1.61% | +2376.9% |
| Q3 2013 | $1,179,000 | +0.4% | 23,500 | 0.0% | 0.06% | +22.6% |
| Q2 2013 | $1,174,000 | – | 23,500 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |